Shengli Li

4.4k total citations · 1 hit paper
128 papers, 2.9k citations indexed

About

Shengli Li is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shengli Li has authored 128 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 46 papers in Cancer Research and 22 papers in Surgery. Recurrent topics in Shengli Li's work include Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (24 papers) and RNA Research and Splicing (19 papers). Shengli Li is often cited by papers focused on Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (24 papers) and RNA Research and Splicing (19 papers). Shengli Li collaborates with scholars based in China, United States and Canada. Shengli Li's co-authors include Xianghuo He, Shenglin Huang, Zhixiang Hu, Yingjun Zhao, Leng Han, Jiwei Zhang, Yuchen Li, Zhe Li, Bing Chen and Qiupeng Zheng and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shengli Li

122 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes

2017 422 citations Shengli Li, Yuchen Li et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Shengli Li	2.1k	1.5k	321	254	203	128	2.9k
Yitian Chen	2.2k 1.1×	1.8k 1.2×	442 1.4×	239 0.9×	243 1.2×	62	3.1k
Xiaoyi Huang	2.0k 1.0×	1.5k 1.0×	277 0.9×	317 1.2×	216 1.1×	108	2.9k
Xiaohui Xu	1.5k 0.7×	1.0k 0.7×	366 1.1×	232 0.9×	217 1.1×	112	2.6k
Bing Chen	2.0k 1.0×	1.2k 0.8×	470 1.5×	375 1.5×	231 1.1×	151	3.1k
Gieri Camenisch	1.9k 0.9×	1.9k 1.3×	329 1.0×	302 1.2×	242 1.2×	39	3.5k
Yu Xiang	2.0k 0.9×	1.1k 0.8×	263 0.8×	419 1.6×	153 0.8×	75	2.9k
Zhen Wang	1.6k 0.7×	1.3k 0.9×	406 1.3×	346 1.4×	193 1.0×	138	2.6k
Dejia Li	2.3k 1.1×	1.4k 1.0×	179 0.6×	114 0.4×	174 0.9×	65	3.0k
Yanli Wang	1.7k 0.8×	1.0k 0.7×	188 0.6×	165 0.6×	122 0.6×	74	2.3k

Countries citing papers authored by Shengli Li

Since Specialization

Citations

This map shows the geographic impact of Shengli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengli Li more than expected).

Fields of papers citing papers by Shengli Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengli Li. The network helps show where Shengli Li may publish in the future.

Co-authorship network of co-authors of Shengli Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengli Li. A scholar is included among the top collaborators of Shengli Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengli Li. Shengli Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jingjun, Duo Gao, Yi Yue, et al.. (2025). Integrating Subacute Ruminal Acidosis, Lipopolysaccharide, and Trained Immunity: A Comprehensive Review. International Journal of Biological Sciences. 21(6). 2806–2823. 1 indexed citations

Yang, Feng, Mengya Wang, Shengli Li, et al.. (2025). Evaluation of microgaps and microleakage at the implant-abutment interface of individualized abutments in the maxillary anterior region under functional loading: A pragmatic clinical trial. Journal of Prosthodontic Research. 69(1). 58–67. 1 indexed citations

Luo, Shengnan, et al.. (2025). Long-read RNA sequencing dataset of human pancreatic cancer cell lines. Scientific Data. 12(1). 1653–1653.

Liao, Tian, Yu Zeng, Weibo Xu, et al.. (2025). A spatially resolved transcriptome landscape during thyroid cancer progression. Cell Reports Medicine. 6(4). 102043–102043. 5 indexed citations

Wang, Yueqi, Shengli Li, Xiaobo Bo, et al.. (2024). CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma. Clinical and Translational Medicine. 14(10). e70060–e70060. 5 indexed citations

Feng, Jiling, Hao Wu, & Shengli Li. (2024). Noncanonical translation of circRNAs drive antitumor immunity. Trends in cancer. 10(2). 100–102. 3 indexed citations

Liu, Yaoming, Wei Hu, Yanjie Xie, et al.. (2024). Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. Communications Biology. 7(1). 11–11. 9 indexed citations

Wang, Hao, et al.. (2023). Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis. Journal of Gynecologic Oncology. 35(2). e13–e13. 8 indexed citations

Lu, Yicheng, Zhenzhen Duan, Jingni Wu, et al.. (2023). Nanopore long-read RNA sequencing reveals functional alternative splicing variants in human vascular smooth muscle cells. Communications Biology. 6(1). 1104–1104. 8 indexed citations

10.

Li, Shengli, Yuan Li, Zhiyuan Xu, et al.. (2023). Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature Communications. 14(1). 778–778. 24 indexed citations

11.

Li, Chunbo, Hao Wu, Luopei Guo, et al.. (2022). Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer. Communications Biology. 5(1). 1208–1208. 62 indexed citations

12.

Wu, Jingni, Wei Hu, & Shengli Li. (2022). Long-read transcriptome sequencing reveals allele-specific variants at high resolution. Trends in Genetics. 39(1). 31–33. 4 indexed citations

13.

Zhang, Jiwei, Shengli Li, Jianian Zhang, et al.. (2022). Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway. Cancer Letters. 545. 215829–215829. 14 indexed citations

14.

Li, Shengli, et al.. (2020). LINC00511 exacerbated T-cell acute lymphoblastic leukemia via miR-195-5p/LRRK1 axis. Bioscience Reports. 40(5). 13 indexed citations

15.

Hu, Zhixiang, Liangqing Dong, Shengli Li, et al.. (2019). Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box–Dependent Interacting Protein 1 in Hepatocellular Carcinoma. Hepatology. 72(2). 548–568. 50 indexed citations

16.

Li, Shengli, Zhixiang Hu, Yingjun Zhao, Shenglin Huang, & Xianghuo He. (2018). Transcriptome‐Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer. Hepatology. 69(1). 359–375. 92 indexed citations

17.

Yu, Tao, Yingjun Zhao, Zhixiang Hu, et al.. (2017). MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Research. 77(21). 5782–5794. 142 indexed citations

18.

Dai, Tingting, et al.. (2017). Overexpression of Prox1 Induces the Differentiation of Human Adipose-Derived Stem Cells into Lymphatic Endothelial-Like Cells In Vitro. Cellular Reprogramming. 19(1). 54–63. 15 indexed citations

19.

Shao, Tingting, Zheng Zhao, Aiwei Wu, et al.. (2015). Functional dissection of virus–human crosstalk mediated by miRNAs based on the VmiReg database. Molecular BioSystems. 11(5). 1319–1328. 8 indexed citations

20.

Bai, Jing, Yongsheng Li, Tingting Shao, et al.. (2014). Integrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer. Molecular BioSystems. 10(9). 2317–2328. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact